Page 48 - Read Online

Page 18 of 23 ALHulais et al. J Cancer Metastasis Treat 2019;5:3 I http://dx.doi.org/10.20517/2394-4722.2018.71

43. Sukowati CH, Rosso N, Pascut D, Anfuso B, Torre G, et al. Gene and functional up-regulation of the BCRP/ABCG2 transporter in
hepatocellular carcinoma. BMC Gastroenterol 2012;12:160.
44. Porro A, Haber M, Diolaiti D, Iraci N, Henderson M, et al. Direct and coordinate regulation of ATP-binding cassette transporter genes by
Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells. J Biol Chem
2010;285:19532-43.
45. Chikazawa N, Tanaka H, Tasaka T, Nakamura M, Tanaka M, et al. Inhibition of Wnt signaling pathway decreases chemotherapy-resistant
side-population colon cancer cells. Anticancer Res 2010;30:2041-8.
46. Chang YW, Su YJ, Hsiao M, Wei KC, Lin WH, et al. Diverse targets of beta-catenin during the epithelial-mesenchymal transition define
cancer stem cells and predict disease relapse. Cancer Res 2015;75:3398-410.
47. Ding XW, Wu JH, Jiang CP. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci
2010;86:631-7.
48. Alowaidi F, Hashimi SM, Alqurashi N, Alhulais R, Ivanovski S, et al. Assessing stemness and proliferation properties of the newly
established colon cancer ‘stem’ cell line, CSC480 and novel approaches to identify dormant cancer cells. Oncol Rep 2018;39:2881-91.
49. Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of
epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A 1997;94:12425-30.
50. Glumac PM, LeBeau AM. The role of CD133 in cancer: a concise review. Clin Transl Med 2018;7:18.
51. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res
2003;63:5821-8.
52. Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG. Colorectal cancer stem cells. Stem Cells 2012;30:363-71.
53. O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
Nature 2007;445:106-10.
54. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell
Death Differ 2008;15:504-14.
55. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res
2005;65:10946-51.
56. Chen H, Luo Z, Dong L, Tan Y, Yang J, et al. CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell
survival. PLoS One 2013;8:e56878.
57. Lin SH, Liu T, Ming X, Tang Z, Fu L, et al. Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133
under low glucose conditions. Sci Rep 2016;6:21184.
58. Du L, Wang H, He L, Zhang J, Ni B, et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res
2008;14:6751-60.
59. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. CD133 expression is not restricted to stem cells, and both CD133+ and
CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-20.
60. Misra S, Hascall VC, Berger FG, Markwald RR, Ghatak S. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer. Connect Tissue Res
2008;49:219-24.
61. Ghatak S, Misra S, Toole BP. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma
cells. J Biol Chem 2005;280:8875-83.
62. Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities
of inflammation and cancer. Front Immunol 2015;6:201.
63. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive
properties: an early step necessary for metastasis. Breast Cancer Res 2006;8:R59.
64. Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA. Prostate cancer invasion is influenced more by expression of a CD44 isoform including
variant 9 than by Muc18. Lab Invest 2004;84:894-907.
65. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-7.
66. Cortes-Dericks L, Froment L, Boesch R, Schmid RA, Karoubi G. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show
ALDH(high)CD44(+) phenotype and sphere-forming capacity. BMC Cancer 2014;14:304.
67. Ohno Y, Shingyoku S, Miyake S, Tanaka A, Fudesaka S, et al. Differential regulation of the sphere formation and maintenance of cancer-
initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways. Oncogene 2018;37:6357-67.
68. Paradis V, Eschwege P, Loric S, Dumas F, Ba N, et al. De novo expression of CD44 in prostate carcinoma is correlated with systemic
dissemination of prostate cancer. J Clin Pathol 1998;51:798-802.
69. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc
Natl Acad Sci U S A 2003;100:3983-8.
70. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. In vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev 2003;17:1253-70.
71. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, et al. Highly purified CD44+ prostate cancer cells from xenograft human
tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006;25:1696-708.
72. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that
provide a model for patients with poor prognosis. Br J Cancer 2008;98:756-65.
73. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U
S A 2007;104:10158-63.
74. Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells
driving colon cancer metastasis. Cell Stem Cell 2014;14:342-56.
75. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. Identification of a subpopulation of cells with cancer stem cell